Anelixis Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $108M

Anelixis Therapeutics General Information

Description

Operator of a biotechnology company intended to facilitate pre-clinical drug development of a novel anti CD40L antibody. The company's portfolio is focused on immune-modulatory drugs for neurodegenerative diseases with a focus on amyotrophic lateral sclerosis (ALS) and Alzheimer's Disease (AD), enabling medical practitioners and researchers to advance treatments that will have a meaningful impact on the lives of patients by helping them battle back their disease progression.

Contact Information

Website
www.anelixistherapeutics.com
Formerly Known As
Anelixis Pharmaceuticals
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 300 Technology Square
  • Suite 400
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Eledon Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 300 Technology Square
  • Suite 400
  • Cambridge, MA 02139
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anelixis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 14-Sep-2020 $108M Completed Clinical Trials - General
11. Later Stage VC 01-Mar-2020 Completed Clinical Trials - General
10. Seed Round 15-May-2019 Completed Clinical Trials - General
9. Seed Round 25-Apr-2018 Completed Pre-Clinical Trials
8. Grant 01-Aug-2017 Completed Pre-Clinical Trials
7. Seed Round 20-Jun-2017 Completed Pre-Clinical Trials
6. Grant 01-Jan-2017 Completed Pre-Clinical Trials
5. Grant 01-Aug-2016 Completed Pre-Clinical Trials
4. Grant 01-May-2016 $800K Completed Pre-Clinical Trials
3. Grant 01-Jan-2016 $1.2M Completed Pre-Clinical Trials
To view Anelixis Therapeutics’s complete valuation and funding history, request access »

Anelixis Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to facilitate pre-clinical drug development of a novel anti CD40L antibody.
Drug Discovery
Cambridge, MA
2 As of 2019

South San Francisco, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anelixis Therapeutics Competitors (20)

One of Anelixis Therapeutics’s 20 competitors is IRulya Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IRulya Therapeutics Formerly VC-backed South San Francisco, CA
Alector Formerly VC-backed South San Francisco, CA
CuraSen Venture Capital-Backed San Carlos, CA
Xenetic Biosciences Corporation Framingham, MA
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
You’re viewing 5 of 20 competitors. Get the full list »

Anelixis Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anelixis Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
BVF Partners Hedge Fund Minority
To view Anelixis Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Anelixis Therapeutics FAQs

  • When was Anelixis Therapeutics founded?

    Anelixis Therapeutics was founded in 2012.

  • Where is Anelixis Therapeutics headquartered?

    Anelixis Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Anelixis Therapeutics?

    Anelixis Therapeutics has 2 total employees.

  • What industry is Anelixis Therapeutics in?

    Anelixis Therapeutics’s primary industry is Drug Discovery.

  • Is Anelixis Therapeutics a private or public company?

    Anelixis Therapeutics is a Private company.

  • What is the current valuation of Anelixis Therapeutics?

    The current valuation of Anelixis Therapeutics is .

  • What is Anelixis Therapeutics’s current revenue?

    The current revenue for Anelixis Therapeutics is .

  • How much funding has Anelixis Therapeutics raised over time?

    Anelixis Therapeutics has raised $16.9M.

  • Who are Anelixis Therapeutics’s investors?

    BVF Partners has invested in Anelixis Therapeutics.

  • Who are Anelixis Therapeutics’s competitors?

    IRulya Therapeutics, Alector, CuraSen, Xenetic Biosciences, and Aro Biotherapeutics are some of the 20 competitors of Anelixis Therapeutics.

  • When was Anelixis Therapeutics acquired?

    Anelixis Therapeutics was acquired on 14-Sep-2020.

  • Who acquired Anelixis Therapeutics?

    Anelixis Therapeutics was acquired by Eledon Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process